Evaluation of the association between health insurance status and healthcare utilization and expenditures among adult cancer survivors in the United States

被引:3
|
作者
Kamat, Shweta [1 ,2 ]
Kogut, Stephen [1 ]
Buchanan, Ashley L. [1 ]
Vyas, Ami [1 ]
机构
[1] Univ Rhode Isl, Coll Pharm, Dept Pharm Practice, Kingston, RI 02881 USA
[2] Univ Rhode Isl, Coll Pharm, Dept Pharm Practice, 7 Greenhouse Rd, Kingston, RI 02881 USA
基金
美国国家卫生研究院;
关键词
Cancer survivors; Health care expenditures; Insurance coverage; Medical expenditure panel survey; BURDEN; DISABILITY; COST; PROJECTIONS; DISPARITIES; PREVALENCE; STATISTICS; DIAGNOSIS; RECEIPT; MODELS;
D O I
10.1016/j.sapharm.2023.02.005
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background: Health care expenditures for cancer care has increased significantly over the past decade and is further projected to rise. This study examined the associations between health insurance status and total direct health care expenditures and health care utilization among cancer survivors living in the United States.Methods: A cross-sectional study of cancer survivors aged >= 18 years, identified from the Medical Expenditures Panel Survey (MEPS) during 2017 using International Classification of Diseases, Tenth Revision codes specific for cancer. Health insurance was categorized into Private, Medicare, Medicaid, and uninsured. Multivariable ordinary least squares regression was used to examine the association between log expenditures and health insurance. Negative binomial regression with log link was used to obtain adjusted incident rate ratios (AIRR) for health care utilization. Survey weights were used to produce nationally representative estimates of the US population.Results: A total of 1140 (weighted = 13.9 million) cancer survivors were identified. Compared to the adjusted mean annual health care expenditures for the private group ($14,265; 95% confidence interval (CI): $12,645 to $16,092), the adjusted mean annual health care expenditures for the Medicare group were higher ($15,112; 95% CI: $13,361 to $17,092). As compared to the private group, the average annual expenditures for uninsured cancer survivors ($2315; 95%CI:1038 to $3501) was significantly lower and so was their health care utilization. Adjusted rates of ER visits for Medicaid were twice (AIRR:2.04; SE:0.28; p = 0.001) as compared to privately insured.Conclusions: A difference in the average total direct expenditures between uninsured and privately insured patients was found. Uninsured had the lowest health care utilization while Medicaid reported significantly higher number of ER visits. Despite differences in program structures, health care expenditures across insurance types were similar. Lower utilization of health care services among uninsured suggests cost maybe a barrier to accessing care.
引用
收藏
页码:821 / 829
页数:9
相关论文
共 50 条
  • [31] Evaluation of health perceptions and healthcare utilization among population-based female cancer survivors and cancer-free women
    Kate E. Dibble
    Maneet Kaur
    Junrui Lyu
    Avonne E. Connor
    Cancer Causes & Control, 2022, 33 : 49 - 62
  • [32] Psychological distress and mental health care utilization among Black survivors of adolescent and young adult cancer
    Choi, Eunju
    Berkman, Amy M.
    Battle, Aryce
    Betts, Andrea C.
    Salsman, John M.
    Milam, Joel
    Andersen, Clark R.
    Miller, Kimberly A.
    Peterson, Susan K.
    Lu, Qian
    Cheung, Christabel K.
    Livingston, J. A.
    Hildebrandt, Michelle A. T.
    Parsons, Susan K.
    Freyer, David R.
    Roth, Michael E.
    CANCER, 2024, 130 (17) : 3011 - 3022
  • [33] Association between patient-reported financial burden and catastrophic health expenditures in cancer survivors
    Uppal, Nishant
    Broekhuis, Jordan M.
    Gomez-Mayorga, Jorge L.
    Chen, Hao Wei
    Chaves, Natalia
    James, Benjamin
    HEALTHCARE-THE JOURNAL OF DELIVERY SCIENCE AND INNOVATION, 2024, 12 (04):
  • [34] Association between multimorbidity trajectories, healthcare utilization, and health expenditures among middle-aged and older adults: China Health and Retirement Longitudinal Study
    Zhang, Zeyun
    Yuan, Manqiong
    Shi, Kanglin
    Xu, Chuanhai
    Lin, Jianlin
    Shi, Zaixing
    Fang, Ya
    JOURNAL OF AFFECTIVE DISORDERS, 2023, 330 : 24 - 32
  • [35] Racial and Ethnic Differences in Health Behaviors and Preventive Health Services Among Prostate Cancer Survivors in the United States
    Li, Jun
    Thompson, Trevor D.
    Richards, Thomas B.
    Steele, C. Brooke
    PREVENTING CHRONIC DISEASE, 2016, 13
  • [36] Disparities in the management and outcome of cervical cancer in the United States according to health insurance status
    Churilla, Thomas
    Egleston, Brian
    Dong, Yanqun
    Shaikh, Talha
    Murphy, Colin
    Mantia-Smaldone, Gina
    Chu, Christina
    Rubin, Stephen
    Anderson, Penny
    GYNECOLOGIC ONCOLOGY, 2016, 141 (03) : 516 - 523
  • [37] Impact of Health Insurance Status on Prostate Cancer Treatment Modality Selection in the United States
    Bledsoe, Trevor J.
    Park, Henry S.
    Rutter, Charles E.
    Aneja, Sanjay
    Nguyen, Paul L.
    Yu, James B.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2018, 41 (11): : 1062 - 1068
  • [38] Chronic comorbid conditions among adult cancer survivors in the United States: Results from the National Health Interview Survey, 2002-2018
    Jiang, Changchuan
    Deng, Lei
    Karr, Matthew A.
    Wen, Yumeng
    Wang, Qian
    Perimbeti, Stuthi
    Shapiro, Charles L.
    Han, Xuesong
    CANCER, 2022, 128 (04) : 828 - 838
  • [39] Quantitative associations between health insurance and stage of melanoma at diagnosis among nonelderly adults in the United States
    Abudu, Boya
    Cook, Kaitlyn A.
    Gershenwald, Jeffrey E.
    Cohen, Philip R.
    Geller, Alan C.
    CANCER, 2020, 126 (04) : 775 - 781
  • [40] The Benefits of Supplementary Private Health Insurance for Healthcare Utilization and Survival among Stomach Cancer Patients
    Kang, Sungwook
    Kwon, Young Dae
    Yu, Chang Hoon
    Noh, Jae Hyung
    Kim, Sung
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2009, 217 (03) : 243 - 250